A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD)
Clinical trial NCT05428033 · COMPLETED
Trial details
- NCT number
- NCT05428033
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2025-03-17
- Enrollment
- 574
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.